Active	Status	Sponsor type	Region	Phase	Filter
2 Active 0 Inactive 2 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
AMG 329 / Amgen
NCT06312020: A Phase 2 Study to Investigate Efficacy and Safety of HZN-1116 in Participants With Sjogren's Syndrome	Recruiting	2	262	Europe, US, RoW	HZN-1116, VIB1116, Placebo	Amgen	Sjogren's Syndrome	06/26	02/27
VIB1116.P1.S1, NCT04948099: A Study of Single and Multiple Ascending Doses of VIB1116 in Rheumatic Diseases	Completed	1	73	Europe, US	VIB1116, Placebo	Amgen	Dendritic Cell -Mediated Rheumatic Diseases	07/23	07/23